Case Report: Covid-19 in Multiple Sclerosis Patients Treated With Ocrelizumab: A Case Series

Introduction: Limited data are available on the course of Coronavirus disease 2019 (COVID-19) in people with Multiple Sclerosis (MS). More real-world data are needed to help the MS community to manage MS treatment properly. In particular, it is important to understand the impact of immunosuppressive...

Descripción completa

Detalles Bibliográficos
Autores principales: De Mercanti, Stefania F., Vercellino, Marco, Bosa, Chiara, Alteno, Anastasia, Schillaci, Valentina, Clerico, Marinella, Cavalla, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563620/
https://www.ncbi.nlm.nih.gov/pubmed/34744958
http://dx.doi.org/10.3389/fneur.2021.691616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563620/
https://www.ncbi.nlm.nih.gov/pubmed/34744958
http://dx.doi.org/10.3389/fneur.2021.691616

Ejemplares similares